Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

DASH PHARMS

  • FDA Approval
  • Nov. 06, 2023, 12:46 UTC
  • 35
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

MYLAN

  • FDA Approval
  • Nov. 06, 2023, 12:46 UTC
  • 34
  • 0 comments

FDA approve ROPINIROLE HYDROCHLORIDE

Comment Full text

BAXTER HLTHCARE

  • FDA Approval
  • Nov. 03, 2023, 19:23 UTC
  • 36
  • 0 comments

FDA approve PENICILLIN G POTASSIUM

Comment Full text

RISING

  • FDA Approval
  • Nov. 03, 2023, 11:43 UTC
  • 34
  • 0 comments

FDA approve ACETYLCYSTEINE

Comment Full text

GLENMARK GENERICS

  • FDA Approval
  • Nov. 02, 2023, 11:46 UTC
  • 27
  • 0 comments

FDA approve CARVEDILOL

Comment Full text

SANOFI AVENTIS US

  • FDA Approval
  • Nov. 02, 2023, 11:46 UTC
  • 32
  • 0 comments

FDA approve ISATUXIMAB-IRFC

Comment Full text

MEITHEAL

  • FDA Approval
  • Nov. 02, 2023, 11:46 UTC
  • 24
  • 0 comments

FDA approve PANTOPRAZOLE SODIUM

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Nov. 02, 2023, 11:46 UTC
  • 27
  • 0 comments

FDA approve VENLAFAXINE HYDROCHLORIDE

Comment Full text

TEVA

  • FDA Approval
  • Nov. 02, 2023, 11:46 UTC
  • 27
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

YICHANG HUMANWELL

  • FDA Approval
  • Nov. 02, 2023, 11:46 UTC
  • 29
  • 0 comments

FDA approve DESVENLAFAXINE SUCCINATE

Comment Full text
  • Previous
  • 639
  • 640
  • 641
  • 642
  • 643
  • Next

Search

News categories

  • Technical Exchange News(11967)
  • Event(4993)
  • SEC News(246619)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(148699)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin